ExploreWatchlistsPricing
  1. JP-listed companies
  2. SANTEN PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Total assets

SANTEN PHARMACEUTICAL CO.,LTD. (4536)

Market cap
¥615.9B
P/E ratio
17.5x
Santen Pharmaceutical develops and sells eye care medicines and medical devices worldwide, specializing in ophthalmology products for both prescription and over-the-counter markets.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal assets (Million JPY)YoY (%)
Mar 31, 2025409,277-6.06%
Mar 31, 2024435,699+3.45%
Mar 31, 2023421,179-8.43%
Mar 31, 2022459,976+14.32%
Mar 31, 2021402,353-1.57%
Mar 31, 2020408,768+4.49%
Mar 31, 2019391,186+0.70%
Mar 31, 2018388,463+20.35%
Mar 31, 2017322,778-9.18%
Mar 31, 2016355,399+16.83%
Mar 31, 2015304,200

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat